Evidence map›Paper›PMID 24376674›Full record

ArticlePloS one2013

Characterization of SLCO5A1/OATP5A1, a solute carrier transport protein with non-classical function.

Katrin Sebastian, Silvia Detro-Dassen, Natalie Rinis, Dirk Fahrenkamp, Gerhard Müller-Newen, Hans F Merk, Günther Schmalzing, Gabriele Zwadlo-Klarwasser, Jens Malte Baron

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Differential Associations of SLCO Transporters with Prostate Cancer Aggressiveness between African Americans and European Americans.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Katrin SebastianDepartment of Dermatology and Allergology, University Hospital RWTH Aachen, Aachen, Germany.
Silvia Detro-DassenInstitute of Pharmacology and Toxicology, Medical Faculty of the RWTH Aachen University, Aachen, Germany.
Natalie RinisInstitute of Biochemistry and Molecular Biology, Medical Faculty of the RWTH Aachen University, Aachen, Germany.
Dirk FahrenkampInstitute of Biochemistry and Molecular Biology, Medical Faculty of the RWTH Aachen University, Aachen, Germany.
Gerhard Müller-NewenInstitute of Biochemistry and Molecular Biology, Medical Faculty of the RWTH Aachen University, Aachen, Germany.
Hans F MerkDepartment of Dermatology and Allergology, University Hospital RWTH Aachen, Aachen, Germany.
Günther SchmalzingInstitute of Pharmacology and Toxicology, Medical Faculty of the RWTH Aachen University, Aachen, Germany.
Gabriele Zwadlo-KlarwasserInterdisciplinary Center for Clinical Research (IZKF), Medical Faculty of the RWTH Aachen University, Aachen, Germany.
Jens Malte BaronDepartment of Dermatology and Allergology, University Hospital RWTH Aachen, Aachen, Germany.
RWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organic anion transporting polypeptides (OATP/SLCO) have been identified to mediate the uptake of a broad range of mainly amphipathic molecules. Human OATP5A1 was found to be expressed in the epithelium of many cancerous and non-cancerous tissues throughout the body but protein characterization and functional analysis have not yet been performed. This study focused on the biochemical characterization of OATP5A1 using Xenopus laevis oocytes and Flp-In T-REx-HeLa cells providing evidence regarding a possible OATP5A1 function. SLCO5A1 is highly expressed in mature dendritic cells compared to immature dendritic cells (∼6.5-fold) and SLCO5A1 expression correlates with the differentiation status of primary blood cells. A core- and complex- N-glycosylated polypeptide monomer of ∼105 kDa and ∼130 kDa could be localized in intracellular membranes and on the plasma membrane, respectively. Inducible expression of SLCO5A1 in HeLa cells led to an inhibitory effect of ∼20% after 96 h on cell proliferation. Gene expression profiling with these cells identified immunologically relevant genes (e.g. CCL20) and genes implicated in developmental processes (e.g. TGM2). A single nucleotide polymorphism leading to the exchange of amino acid 33 (L→F) revealed no differences regarding protein expression and function. In conclusion, we provide evidence that OATP5A1 might be a non-classical OATP family member which is involved in biological processes that require the reorganization of the cell shape, such as differentiation and migration.

Indexed as

Gene Expression RegulationAnimalsCell DifferentiationCell MembraneCell MovementCell ShapeDendritic CellsGene Expression ProfilingHeLa CellsHumansIntracellular MembranesIon TransportOocytesOrganic Anion TransportersPolymorphism, Single NucleotideXenopus laevisOrganic Anion TransportersSLCO5A1 protein, human

Identifiers

PMID24376674
PMCPMC3869781
OpenAlexW2078643567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.